Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.055
+0.035 (3.43%)
At close: Aug 29, 2025, 4:00 PM
1.020
-0.035 (-3.32%)
After-hours: Aug 29, 2025, 7:57 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $5.42 million as of August 29, 2025. Its market cap has increased by 44.81% in one year.
Market Cap
5.42M
Enterprise Value
803.02K
1-Year Change
44.81%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $5.42M, a decrease of -79.30%. That is a compound annual growth rate of -32.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 5.42M | -10.44% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
| Aug 16, 2021 | 26.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.27B |
| Johnson & Johnson | 425.89B |
| AbbVie | 367.78B |
| UnitedHealth Group | 275.76B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 247.04B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.44B |